TerryJFryMD

Pediatric Hematology & Oncology • Aurora, CO

Professor, Pediatrics and Immunology

Join to view full profile

Dr. Fry is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fry's full profile

Already have an account?

Office
13123 East 16th Avenue
Box B115 CCBD
Aurora, CO 80045
Phone+1 720-777-6458

Fax+1 720-777-7279

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1996 - 1999
MedStar Health/Georgetown University HospitalResidency, Pediatrics, 1992 - 1996
Georgetown University School of MedicineClass of 1992

Certifications & Licensure

CO State Medical License 2018 - 2025
MD State Medical License 1995 - 2018
DC State Medical License 1995 - 2016
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies Start of enrollment: 2001 Mar 14
Completed
Early Phase 1

Publications & Presentations

PubMed

Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic le...
Tommaso Balestra, Lisa M Niswander, Asen Bagashev, Joseph P Loftus, Savannah L Ross
Leukemia. 2024-12-16
Two decades of advances in clinical oncology - lessons learned and future directions.
Susana Banerjee, Christopher M Booth, Eduardo Bruera, Markus W Büchler, Alexander Drilon
Nature Reviews. Clinical Oncology. 2024-11-01
3 citations
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome.
Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, Chintan Chhatbar, Rachael C Adams
Nature Cancer. 2024-08-01

Abstracts/Posters

Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL)
Terry J. Fry, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Infectious Complications Associated with CAR T-Cell Therapy
Terry J. Fry, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

The Role of Biomarkers in Guiding Immunotherapeutic Clinical Decisions
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

CU Anschutz Takes the Reins in CAR T Cancer Therapy ResearchMay 8th, 2023
University of Colorado to Invest $200 Million in New Regenerative Medicine InstituteMay 12th, 2022
For Childhood Eye Cancer, Researchers Investigating “Packaged” CAR T CellsNovember 10th, 2020
Join now to see all